Roxadustat Does Not Affect Platelet Production, Activation, and Thrombosis Formation.

ABSTRACT: Objective: Roxadustat is a new medication for the treatment of renal anemia. EPO (erythropoietin)-the current treatment standard-has been reported to enhance platelet activation and production. However, to date, the effect of roxadustat on platelets is unclear. To address this deficiency, herein, we have evaluated the effect of roxadustat on platelet production and function.

SUBMITTER: Zhao J 

PROVIDER: S-EPMC8454499 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature